BioMark Diagnostics Inc
SWB:20B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of BioMark Diagnostics Inc (20B) under the Base Case is EUR per share. Compared with the current market price of 0.244 EUR, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What BioMark Diagnostics Does
BioMark Diagnostics Inc. is a molecular diagnostics company that develops blood- and urine-based tests for cancer detection and monitoring. Its products are meant to help find signs of disease earlier, support diagnosis, and track whether cancer is returning or responding to treatment. The company’s work centers on biomarker testing, where it looks for biological signals linked to specific cancers rather than selling drugs or hospital equipment.
- Headquarters
- Canada CA
- IPO date
- Nov 3, 2014
Revenue & Expenses Breakdown
BioMark Diagnostics Inc
Earnings Waterfall
BioMark Diagnostics Inc
What is the Intrinsic Value of one 20B stock?
The intrinsic value for BioMark Diagnostics Inc (20B) under the Base Case is EUR.
Is 20B stock undervalued or overvalued?
Compared with the current market price of 0.244 EUR, the stock appears .